About 100 reports

  • FILGRASTIM - DRUG PROFILE
  • FILGRASTIM - DRUG PROFILE
  • Cell Therapy
  • Chemotherapy
  • United States
  • Product Initiative
  • GlycoMimetics, Inc.
  • Therapy Area Indication(s)
  • Clinical Trial profile. 270 Trial Title
  • Cell Therapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative

Filgrastim in Treating Patients with Burkitt' s Lymphoma or Burkitt' s Leukemia GDCT## NCT##, U##CA##; CALGB-##; CDR## Oncology Burkitt Lymphoma, Leukemias, Lymphoma Completed Phase II Interventional allopurinol; cyclophosphamide; cytarabine; dexamethasone; doxoru

  • Cell Therapy
  • HIV AIDS
  • Lymphoma
  • World
  • Product Initiative
  • Clinical Trial profile. 161 Trial Title
  • Clinical Trial profile. 223 Trial Title

filgrastim; sargramostim Fred Hutchinson Cancer Research Center ## Mar 1995 ## Oct 1997 ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Collaborato

  • Biological Therapy
  • Blood Disease
  • Cell Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 247 Trial Title
  • Cancer
  • Cell Therapy
  • United States
  • World
  • Novartis AG
  • Clinical Trial profile. 33 Trial Title
  • Clinical Trial profile. 61 Trial Title

filgrastim ## fludarabine anti-thymocyte globulin busulfan ## ## ## plerixafor ## Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of August 2017 ## CLINICAL TRIAL PROFILE SNAPSHOTS N

  • Blood Disease
  • Cell Therapy
  • Therapy
  • World
  • Product Initiative

filgrastim ## FLX-## ## ibudilast ## Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of March 2017 ## Latest Clinical Trials News on Amyotrophic Lateral Sclerosis MAR ##, 2017: CO

  • Cell Therapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative

Filgrastim or Lenograstim or CSF##)) Completed Phase I Interventional busulfan; filgrastim; melphalan; peripheral blood stem cells; thiotepa Fred Hutchinson Cancer Research Center National Cancer Institute US ## Mar 1998 ## Jan 2002 ## ## ## ## A Phase I Study of the Chemoprotectant A

  • Cancer
  • Cell Therapy
  • World
  • Product Initiative
  • Eli Lilly & Co.
  • Clinical Trial profile. 24 Trial Title

Flexible Filgrastim to Accelerate Bone Marrow Recovery after Chemotherapy in Children with Cancer GDCT## NCT##, 2013-##; NCI-2013-02001; 2013-##; P##CA##; CDR## Oncology Brain Tumor, Germ Cell Tumors, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Medulloblastoma, Neuroblastom

  • Cell Therapy
  • Chemotherapy
  • Clinical Trial
  • United States
  • World
  • R&D Progress Research and Development Brief
  • Blood Disease
  • Cell Therapy
  • Pathology
  • United States
  • Product Initiative
  • Clinical Trial profile. 228 Trial Title

filgrastim; ifosfamide; melphalan; methotrexate; methylprednisolone; pegfilgrastim; prednisolone; rituximab; vincristine sulfate; vindesine sulfate University Hospital Essen Deutsche Krebshilfe eV ## Nov 2007 ## Mar 2017 ## ## ## ## ## DNA Synthesis Inhibitor DNA Clinical Trial profile. ##

  • Cell Therapy
  • Lymphoma
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Cancer
  • Cell Therapy
  • Pathology
  • World
  • Product Initiative

Filgrastim targets G-CSF receptor.

  • Cell Therapy
  • Transplantation
  • United States
  • Product Initiative
  • Pluristem Therapeutics Inc.
  • Clinical Trial profile. 90 Trial Title

filgrastim; melphalan Boston Medical Center National Institutes of Health ## Nov 2000 ## Jun 2005 ## ## ## ## ## DNA Synthesis Inhibitor DNA A Multicenter Phase II Trial of Bortezomib (Velcade), Melphalan and Dexamethasone (V-MD) in Patients with Symptomatic AL-Amyloidosis or Light Chain Depo

  • Cell Therapy
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 918 Trial Title

Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation GDCT## NCT##, Immunology Graft Versus Host Disease (GVHD) Completed Phase III Interventional

  • Cell Therapy
  • Drug Discovery And Development
  • Pharmaceutical
  • United States
  • World

Filgrastim in Promoting Stem Cell Mobilization in Patients with Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant GDCT## NCT##, NCI-2012-##; 2008-##; P##CA## Oncology B-Cell Chronic Lymphocytic Leukemia, Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma

  • Cell Therapy
  • Leukemia
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Clinical Trial profile. 645 Trial Title
  • Clinical Trial profile. 1675 Trial Title

Filgrastim or Lenograstim or CSF##)) Completed Phase III Interventional amsacrine; autologous peripheral blood stem cells; carmustine; cytarabine; etoposide; filgrastim; idarubicin; mitoxantrone European Organization for Research and Treatment of Cancer Gruppo Italiano Malattie EMat

  • Cell Therapy
  • Drug Discovery And Development
  • Leukemia
  • United States
  • World
  • Cell Therapy
  • Clinic
  • World
  • Product Initiative
  • Novartis AG
  • Target
  • Clinical Trial profile. 104 Trial Title

Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors GDCT## NCT##, UC-##; ##-CC-##; NCT## Immunology Hematopoiet

  • Blood Supply, Tissue Banking And Transplantation
  • Cell Therapy
  • Clinical Trial
  • World
  • Product Initiative
  • Clinical Trial profile. 98 Trial Title
  • Cell Therapy
  • Lymphoma
  • World
  • Product Initiative
  • Novartis AG
  • Clinical Trial profile. 500 Trial Title
  • Clinical Trial profile. 1058 Trial Title

filgrastim; fludarabine phosphate; melphalan; natural killer cells; rituximab; T cell-depleted hematopoietic stem cells; thiotepa St.

  • Cell Therapy
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World

filgrastim; prednisone; rituximab; vincristine The Alliance for Clinical Trials in Oncology Montefiore Medical Center ## May 2005 ## May 2018 ## ## ## ## ## Cytotoxic To Cells Expressing B Lymphocyte Antigen CD## (B Lymphocyte Surface Antigen B## or Bp## or Leukocyte Surface Antigen Leu ##

  • Cell Therapy
  • Lymphoma
  • Monoclonal Antibody
  • United States
  • World
  • Clinical Trial profile. 392 Trial Title
  • Clinical Trial profile. 256 Trial Title
  • Cell Therapy
  • Monoclonal Antibody
  • United States
  • World
  • Celgene Corporation
  • Clinical Trial Profile Snapshots

filgrastim; ifosfamide; melphalan Samsung Medical Center ## Sep 2015 ## Nov 2019 ## ## ## DNA Synthesis Inhibitor DNA Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Estimated Start Date Estimated Completion D

  • Cell Therapy
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Celgene Corporation
  • Clinical Trial profile. 137 Trial Title
  • Clinical Trial profile. 40 Trial Title

filgrastim Fred Hutchinson Cancer Research Center ## Aug 2003 ## May 2007 ## ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Collaborator(s) Est

  • Cell Therapy
  • Chemotherapy
  • Monoclonal Antibody
  • World
  • Product Initiative

Filgrastim or Lenograstim or CSF##), Interleukin ## (T Cell Growth Factor or Aldesleukin or IL##)) Terminated Phase I/ II Interventional aldesleukin; allogeneic natural killer cells; cyclophosphamide; fludarabine phosphate; rituximab Masonic Cancer Center National Cancer Institute US ## Ja

  • Cell Therapy
  • Leukemia
  • Lymphoma
  • United States
  • World
  • Clinical Trial profile. 763 Trial Title
  • Clinical Trial profile. 612 Trial Title
  • Cancer
  • Cell Therapy
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 220 Trial Title
  • Clinical Trial profile. 226 Trial Title

filgrastim; fludarabine phosphate; methylprednisolone; mycophenolate mofetil Masonic Cancer Center; University of Minnesota ## Feb 2000 ## Dec 2016 ## ## ## DNA Synthesis Inhibitor DNA Clinical Trial profile. ## Trial Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Sta

  • Blood Disease
  • Cell Therapy
  • Leukemia
  • World
  • Product Initiative

filgrastim; leucovorin; mercaptopurine; methotrexate; pegaspargase; vincristine sulfate Children' ' s Oncology Group National Cancer Institute ## Nov 2004 ## Sep 2013 ## ## ## ## ## DNA Synthesis Inhibitor DNA Clinical Trial profile. ## Trial Title Official Title Compound ##U##

  • Cell Therapy
  • Leukemia
  • World
  • Product Initiative
  • Celgene Corporation

Filgrastim targets G-CSF receptor.

  • Cell Therapy
  • Transplantation
  • United States
  • Product Initiative
  • Pluristem Therapeutics Inc.